glp-1 bacteria A surprising role for enteroendocrine cells and in regulating intestinal inflammation Central glucagon-like peptide 1 receptor

And the clinical results have improved with each step up in receptor complexity

GLP-2 analogs are already approved therapies for short bowel syndrome and are effective at reducing the need for parenteral nutrition in ~65% of individuals 16

Gala GLP-1 Side Effects and Safety Gala GLP-1 may cause side effects, especially during the early adjustment phase

The GLP-1 Revolution: The Science, My Journey, and The Truth About These Weight Loss Drugs (The GLP-1 Living Series)

GLP-1 Side Effects and Cancer Risk: What Current Research Really Shows GLP-1 receptor agonists have become some of the most talked-about medications for diabetes and weight loss

The combination yields greater weight loss than either agent alone, with mean reductions in body weight of approximately 20.4% over 68 weeks in non-diabetic adults and 13.7% in those with type 2 diabetesfar exceeding placebo and monotherapy arms